TENSOPRIL
Natural health product licensed in Canada
- Other names
- KONIG TENSOPRIL
- Licence holder
- Provita Nutrition and Health Inc.
- NPN or DIN-HM
- 80038646
- Status
- Active licence
- Licence date
- 11 January 2013
- Revision date
- Not provided
- Form
- Capsule, dur
- Route of administration
- Orale
- Application type
- Traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Coffea arabica Source : Graine(s) Potency : 50 mg Chlorogenic acids | 100 mg | Not calculated |
| Coffea arabica Source : Graine(s) Potency : 2 mg Caffeine | Not specified | Not calculated |
| Crataegus laevigata Source : Fruit | 75 mg | Not calculated |
| Crataegus laevigata Source : Fruit Extract : Extract Type TBA Extraction ratio : 10:1 Dry plant equivalent : 750 mg | Not specified | Not calculated |
Non-medicinal ingredients
Fleur d'Hibiscus Sabdariffa, L-Glutamate, Dioxyde de silicium, Nitrate de potassium, Gélatine, Oléorésine de poivre noir
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | minimum: 1 Capsule ; maximum: 2 Capsule | 1 day |
Uses authorised in Canada
(Traditionally) used in Herbal Medicine to help maintain and/or support cardiovascular health in adults.Green Coffee Bean Extract helps maintain healthy blood pressure levels.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consult a health care practitioner if symptoms persist or worsen. Consult a health care practitioner prior to use if you are taking cardiac glycosides such as digitalis/digoxin, or blood pressure medication. If you are breastfeeding, consult a healthcare practitioner prior to use. If you are pregnant, do not use this product.
Source
Official Health Canada record, licence 80038646
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.